Expert Opinion On Drug Metabolism & Toxicology

Journal Title：Expert Opinion On Drug Metabolism & Toxicology

Expert Opinion on Drug Metabolism & Toxicology (ISSN 1742-5255 [print], 1744-7607 [electronic]) is a MEDLINE-indexed, peer-reviewed, international journal publishing review articles on all aspects of ADME-Tox. Each article is structured to incorporate the author’s own expert opinion on the scope for future development.

The Editors welcome:

Reviews covering metabolic, pharmacokinetic and toxicological issues relating to specific drugs, drug-drug interactions, drug classes or their use in specific populations; issues relating to enzymes involved in the metabolism, disposition and excretion of drugs; techniques involved in the study of drug metabolism and toxicology; novel technologies for obtaining ADME-Tox data.

Drug Evaluations reviewing the clinical, toxicological and pharmacokinetic data on a particular drug.

The audience consists of scientists and managers in the pharmaceutical industry, pharmacologists, clinical toxicologists and related professionals.

《药物代谢与毒理学专家意见》（ISSN 1742-5255 [印刷版]，1744-7607 [电子版]）是一本 MEDLINE 索引、同行评审的国际期刊，发表有关 ADME-Tox 各个方面的评论文章。每篇文章都包含作者自己对未来发展范围的专家意见。

欢迎编辑：

评论涵盖与特定药物、药物间相互作用、药物类别或其在特定人群中的使用有关的代谢、药代动力学和毒理学问题；与药物代谢、处置和排泄有关的酶有关的问题；药物代谢和毒理学研究所涉及的技术；获取 ADME-Tox 数据的新技术。

药物评估审查特定药物的临床、毒理学和药代动力学数据。

听众包括制药行业的科学家和管理人员、药理学家、临床毒理学家和相关专业人士。

Expert Opinion On Drug Metabolism & Toxicology创刊于2005年，由Taylor and Francis Ltd.出版商出版，收稿方向涵盖医学 - 生化与分子生物学全领域，此刊是中等级别的SCI期刊，所以过审相对来讲不是特别难，但是该刊专业认可度不错，仍然是一本值得选择的SCI期刊 。平均审稿速度 偏慢,4-8周 ，影响因子指数3.9，该期刊近期没有被列入国际期刊预警名单，广大学者值得一试。